Literature DB >> 3778046

Polymicrobial bacterascites. A unique entity in the spectrum of infected ascitic fluid.

B A Runyon, J C Hoefs, H N Canawati.   

Abstract

A retrospective analysis of 1578 abdominal paracenteses revealed ten cases of polymicrobial bacterascites, ie, growth of multiple organisms in ascitic fluid with a neutrophil count less than 250 cells/cu mm. Six of the ten paracenteses that documented this condition were traumatic (bloody or producing feculent material). Clinical peritonitis developed in only one patient. No one died as a result of the infection. Polymicrobial bacterascites is rare (0.6% of paracenteses). It is frequently due to a traumatic paracentesis (bowel entry by the paracentesis needle), and is associated with low morbidity.

Entities:  

Mesh:

Year:  1986        PMID: 3778046     DOI: 10.1001/archinte.146.11.2173

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Prevalence and prognostic significance of bacterascites in cirrhosis with ascites.

Authors:  C M Chu; K Y Chang; Y F Liaw
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

2.  Spontaneous Bacterial Peritonitis: We Are Still Behind.

Authors:  Laith Numan; Ahmed Elkafrawy; Osama Kaddourah; Tim Brotherton; Lyla Saeed; Yousaf Zafar; Andrew Tomaw; John Foxworth; Leen Al-Sayyed
Journal:  Cureus       Date:  2020-04-17

3.  Effect of Hospital Teaching Status on Mortality and Procedural Complications of Percutaneous Paracentesis in the United States: A Four-Year Analysis of the National Inpatient Sample.

Authors:  Mohammad Aldiabat; Yazan Aljabiri; Mohannad H Al-Khateeb; Mubarak H Yusuf; Yassine Kilani; Ali Horoub; Fnu Farukhuddin; Ratib Mahfouz; Adham E Obeidat; Mohammad Darweesh; Mahmoud M Mansour
Journal:  Cureus       Date:  2022-06-24

4.  Bacterascites: A study of clinical features, microbiological findings, and clinical significance.

Authors:  Rosalie C Oey; Henk R van Buuren; David M de Jong; Nicole S Erler; Robert A de Man
Journal:  Liver Int       Date:  2018-08-10       Impact factor: 5.828

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.